NY/NJ CEO
Date: Location: Cost:
November 7 - 8, 2017 Apella at Alexandria Center
450 E. 29 Street
New York, NY 10016
(212) 706-4100
Location >

Starting at $1950

 

Dress Code:
Business Attire

Register

NY/NJ CEO - November 7, 2017 - DRAFT

Co-hosts: Ron Cohen, President & CEO, Acorda; Ron CooperPresident & CEO, Albireo Pharma; Mikael DolstenPresident, WWRD, Pfizer; Carl GordonGeneral Partner, OrbiMed; Glenn GormleyExecutive Chairman & President, Daiichi Sankyo; Glenn KazoCEO, Prolong Pharmaceuticals; Ramesh KumarPresident & CEO, Onconova; Jonathan LewisChairman & CEO, Samus Therapeutics; Francois Nader, Chairman, Acceleron; Jonathan PeacockChairman, Arix Bioscience; Cynthia SchwalmEVP & President, North American Commercial Operations, IPSEN; Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche; Steve TregayCEO, FORMA Therapeutics; Harlan WaksalPresident & CEO, Kadmon; George YancopoulosPresident & CSO, Regeneron Pharmaceuticals

Time Agenda
7:30-8:20 am

Registration & Networking Breakfast

8:20-8:40 am

Welcome and Opening Remarks

8:40-9:10 am

Plenary Session: Major Issues for BioPharma in 2018 and Beyond
Glenn Gormley, Daiichi Sankyo; Ron Cohen, President & CEO, Acorda

9:10-9:30 am

Moderated Keynote: Emerging Areas of Unmet Needs
Mikael Dolsten
President, Worldwide R&D, Pfizer

Moderator: John Nicols, President & CEO, Codexis

9:30-10:00 am

State of the Markets: Biotech and Pharma
Clive Meanwell, CEO, The Medicines Company; Scott Myers, CEO, Cascadian Therapeutics; Ron Squarer, CEO, Array BioPharma; John Tucker, CEO, ScPharmaceuticals
Moderator: Robert Forrester, CEO, Verastem

10:00-10:30 am

Networking Break

10:30-11:00 am

Managing Risk in Early Stage Innovation
Brian McVeigh, VP, WWBD, GlaxoSmithKline; Jonathan Peacock, Chairman, Arix Bioscience, Carl GordonGeneral Partner, OrbiMed

11:00-11:30 am

Alternative Financing Methods
Adam GridleyPresident & CEO, Histogenics; Uli Hacksell, CEO, Cerecor; Matthew Kane, CEO, Precision BioSciences; Glenn KazoPresident, Prolong Pharmaceuticals; Pedro Lichtinger, former CEO, Asterias; Maria Maccecchini, President & CEO, QR Pharma

11:30-12:00 pm

Therapeutic Market Focus: Oncology & Immunotherapy
Parker Cassidy, CCO, Mitra Biotech; Jimmy Lin, CSO, Oncology, Natera; Robert Stein, President, R&D, Agenus

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Big Pharma and Biotech: Impact on Innovation
Harlan Waksal, President & CEO, Kadmon

1:30-2:00 pm

Ensuring Transparency and Drug Value
Luigi Costa
CEO, Nordic Nanovector; Cedric Francois, President & CEO, Apellis Pharmaceuticals; Ramesh Kumar, President & CEO, Onconova; Thomas Lonngren, Former Executive Director, EMA; Sam Waksal, Founder, Kadmon

2:00-2:20 pm

Fireside Chat
Ron Cohen, President & CEO, Acorda

2:20-2:50 pm

Networking Break

2:50-3:20 pm

Accessing Innovation in Drug Discovery: Where and How?
Michael Foley, Sanders Director, Tri-Institutional Therapeutics Discovery Institute; Jonathan Lewis, CEO, Samus Therapeutics

3:20-3:50 pm

Partner or Go it Alone
Ivana Magovcevic-Liebisch
EVP, Chief Strategy & Corp. Dev Officer, Axcella Health; Andrew Hindman, Chief Business Development Officer, Acorda Therapeutics
Moderator: Mark Simon, Partner, Torreya Partners

3:50-4:10 pm

Moderated Keynote

4:10-5:00 pm

Cocktails & Hors d’oeuvres

NY/NJ CEO - November 8, 2017 - DRAFT

Co-hosts: Ron Cohen, President & CEO, Acorda; Ron CooperPresident & CEO, Albireo Pharma; Mikael DolstenPresident, WWRD, Pfizer; Carl GordonGeneral Partner, OrbiMed; Glenn GormleyExecutive Chairman & President, Daiichi Sankyo; Glenn KazoCEO, Prolong Pharmaceuticals; Ramesh KumarPresident & CEO, Onconova; Jonathan LewisChairman & CEO, Samus Therapeutics; Francois Nader, Chairman, Acceleron; Jonathan PeacockChairman, Arix Bioscience; Cynthia SchwalmEVP & President, North American Commercial Operations, IPSEN; Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche; Steve TregayCEO, FORMA Therapeutics; Harlan WaksalPresident & CEO, Kadmon; George YancopoulosPresident & CSO, Regeneron Pharmaceuticals

Time Agenda
7:30-8:30 am

Registration & Networking Breakfast

8:30-8:45 am

Welcome and Opening Remarks

8:45-9:15 am

Healthcare Market Dynamics: Predictions for 2018
Francois NaderChairman, Acceleron Pharma

9:15-9:45 am

Therapeutic Market Focus: Microbiome
Colleen Cutcliffe, CEO, Whole Biome

9:45-10:15 am

The Path from Big Data to Precision Medicine
Aris Baras,
VP & Head, Regeneron Genetics Center, Regeneron Pharmaceuticals; Jeffrey ReidExecutive Director, Head of Genome InformaticsRegeneron Pharmaceuticals

10:15-10:45 am

Networking Break

10:45-11:15 am

Rare Disease Economics: Impact on the Industry
Anil Diwan, President & Chairman, NanoViricides; Iris Perl, CEO, Prize4Life; William Lewis, President & CEOInsmed

11:15-11:45 pm

Small-Cap and Private Biotech: Leveraging Potential
Joseph Payne, President & CEO, Arcturus Therapeutics
Moderator: Lisa McKerracher, CEO, BioAxone Biosciences

11:45-12:15 pm

Moderatated Keynote
Adena Friedman
, CEO, NASDAQ

12:15-12:45 pm

Venture Financing: Maintaining Momentum
Rahul Kakkar, Founder & EVP Clinical and Strategic Development, Cordivia; Charlotte Hubbert, Partner, Gates Foundation Venture Capital

12:45-1:35 pm

Networking Lunch

1:35-2:05 pm

Global Markets: Biotechs Across Borders
Carl Firth, CEO, Aslan Pharmaceuticals; James Sapirstein, CEO, Contravir Pharmaceuticals

 

2:05-2:35 pm

Innovative Deals and Partnerships
Elcin ErgunPresident, New Businesses, EMD Serono; Adam Golden, Partner, Hogan Lovells; Cynthia Schwalm, EVP & President, Commercial Operations, North America, Ipsen
Moderator: Bob SilvermanHead, Externalized Drug Discovery Partnering, Roche

2:35-2:50 pm

Networking Break

2:50-3:20 pm

Biotech Valuations in 2017

3:20-3:50 pm

Building a Biotech: Innovative Business Models
Ron CooperPresident & CEO, Albireo Pharma
Moderator: Steve Tregay, CEO, Forma Therapeutics

3:50-4:10 pm

Fireside Chat
George Yancopoulos, President & CSO, Regeneron Pharmaceuticals

4:10-4:30 pm

Presentation of NY/NJ CEO Lifetime Achievement Award
Presented by: Francois Nader, 2016 Honoree; Ron Cohen, 2013 Honoree; George Yancopoulos, 2012 Honoree

4:30-5:30 pm

Cocktails & Hors d'oeuvres

Premier Sponsors: (see all sponsors)

<